| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.62▼ | 4.65▼ | 4.71▼ | 4.84▼ | 5.05▼ |
| MA10 | 4.63▼ | 4.76▼ | 4.77▼ | 5.05▼ | 4.85▼ |
| MA20 | 4.71▼ | 4.88▼ | 4.91▼ | 5.16▼ | 4.94▼ |
| MA50 | 4.99▼ | 5.11▼ | 5.14▼ | 4.79▼ | 5.65▼ |
| MA100 | 5.12▼ | 5.28▼ | 5.24▼ | 5.20▼ | 6.80▼ |
| MA200 | 5.27▼ | 5.22▼ | 4.92▼ | 5.69▼ | 11.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | -0.020▼ | -0.021▼ | -0.103▼ | 0.059▲ |
| RSI | 31.689▼ | 30.970▼ | 30.368▼ | 40.152▼ | 43.136▼ |
| STOCH | 24.643 | 21.855 | 34.499 | 12.766▼ | 65.827 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -98.155▼ | -58.203 |
| CCI | -62.273 | -84.361 | -98.443 | -156.458▼ | 7.460 |
|
Thursday, September 10, 2026 01:00 AM
"We are delighted to welcome Sanjay to SCYNEXIS and excited to add his extensive financial and strategic leadership experience to our executive team," said David Angulo, M.D., President and Chief ...
|
|
Thursday, March 12, 2026 12:37 AM
On February 26, 2026, SCYNEXIS, Inc. (NASDAQ:SCYX) announced that the first participants had been dosed in a Phase 1 single ascending dose and multiple ascending dose trial evaluating the intravenous ...
|
|
Wednesday, May 28, 2025 09:31 PM
SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold. The hold, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/09/26 | 4.84 | 4.97 | 4.572 | 4.60 | 47,613 |
| 11/09/26 | 4.72 | 5.0586 | 4.72 | 4.84 | 30,448 |
| 10/09/26 | 4.82 | 4.97 | 4.63 | 4.70 | 47,344 |
| 09/09/26 | 5.15 | 5.22 | 4.86 | 4.91 | 58,565 |
| 08/09/26 | 5.30 | 5.35 | 5.15 | 5.15 | 33,070 |
| 04/09/26 | 5.31 | 5.45 | 5.18 | 5.30 | 55,499 |
| 03/09/26 | 5.0301 | 5.37 | 5.0301 | 5.345 | 33,719 |
| 02/09/26 | 5.17 | 5.33 | 5.13 | 5.22 | 39,700 |
| 01/09/26 | 5.33 | 5.34 | 5.11 | 5.17 | 76,079 |
| 31/08/26 | 5.38 | 5.50 | 5.215 | 5.23 | 42,370 |
|
|
||||
|
|
||||
|
|